Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms
Tariq I. Mughal, Thomas Lion, Omar Abdel-Wahab, Ruben Mesa, Robyn M. Scherber, Danilo Perrotti, Michael Mauro, Srdan Verstovsek, Giuseppe Saglio, Richard A. Van Etten, Robert Kralovics
Research output: Contribution to journal › Review article › peer-review
Dive into the research topics of 'Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms'. Together they form a unique fingerprint.